Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 148

1.

Sebaceous carcinoma: evidence-based clinical practice guidelines.

Owen JL, Kibbi N, Worley B, Kelm RC, Wang JV, Barker CA, Behshad R, Bichakjian CK, Bolotin D, Bordeaux JS, Bradshaw SH, Cartee TV, Chandra S, Cho NL, Choi JN, Council ML, Demirci H, Eisen DB, Esmaeli B, Golda N, Huang CC, Ibrahim SF, Jiang SB, Kim J, Kuzel TM, Lai SY, Lawrence N, Lee EH, Leitenberger JJ, Maher IA, Mann MW, Minkis K, Mittal BB, Nehal KS, Neuhaus IM, Ozog DM, Petersen B, Rotemberg V, Samant S, Samie FH, Servaes S, Shields CL, Shin TM, Sobanko JF, Somani AK, Stebbins WG, Thomas JR, Thomas VD, Tse DT, Waldman AH, Wong MK, Xu YG, Yu SS, Zeitouni NC, Ramsay T, Reynolds KA, Poon E, Alam M.

Lancet Oncol. 2019 Dec;20(12):e699-e714. doi: 10.1016/S1470-2045(19)30673-4. Review.

PMID:
31797796
2.

A phase 2 clinical trial assessing the efficacy and safety of pembrolizumab and radiotherapy in patients with metastatic triple-negative breast cancer.

Ho AY, Barker CA, Arnold BB, Powell SN, Hu ZI, Gucalp A, Lebron-Zapata L, Wen HY, Kallman C, D'Agnolo A, Zhang Z, Flynn J, Dunn SA, McArthur HL.

Cancer. 2019 Nov 20. doi: 10.1002/cncr.32599. [Epub ahead of print]

PMID:
31747077
3.

Intravitreous Cutaneous Metastatic Melanoma in the Era of Checkpoint Inhibition: Unmasking and Masquerading.

Francis JH, Berry D, Abramson DH, Barker CA, Bergstrom C, Demirci H, Engelbert M, Grossniklaus H, Hubbard B, Iacob CE, Jaben K, Kurli M, Postow MA, Wolchok JD, Kim IK, Wells JR.

Ophthalmology. 2019 Sep 24. pii: S0161-6420(19)32085-8. doi: 10.1016/j.ophtha.2019.09.018. [Epub ahead of print]

PMID:
31708274
4.

Restaging FDG-PET/CT scan in recurrent cutaneous SCC: Diagnostic performance and prognostic significance.

Mahajan S, Barker CA, Mauguen A, Singh B, Pandit-Taskar N.

J Am Acad Dermatol. 2019 Sep 25. pii: S0190-9622(19)32780-X. doi: 10.1016/j.jaad.2019.09.035. [Epub ahead of print]

PMID:
31562942
5.

Evidence-Based Clinical Practice Guidelines for Microcystic Adnexal Carcinoma: Informed by a Systematic Review.

Worley B, Owen JL, Barker CA, Behshad R, Bichakjian CK, Bolotin D, Bordeaux JS, Bradshaw S, Cartee TV, Chandra S, Cho N, Choi J, Council ML, Eisen DB, Golda N, Huang CC, Ibrahim SF, Jiang SIB, Kim J, Lacutoure M, Lawrence N, Lee EH, Leitenberger JJ, Maher IA, Mann M, Minkis K, Mittal B, Nehal KS, Neuhaus I, Ozog DM, Petersen B, Samie F, Shin TM, Sobanko JF, Somani AK, Stebbins WG, Thomas JR, Thomas V, Tse D, Waldman A, Xu YG, Yu SS, Zeitouni NC, Ramsay T, Poon E, Murad A.

JAMA Dermatol. 2019 Jul 3. doi: 10.1001/jamadermatol.2019.1251. [Epub ahead of print]

PMID:
31268498
6.

Clinical value of 18F-FDG-PET/CT in staging cutaneous squamous cell carcinoma.

Mahajan S, Barker CA, Singh B, Pandit-Taskar N.

Nucl Med Commun. 2019 Jul;40(7):744-751. doi: 10.1097/MNM.0000000000001029.

PMID:
31095044
7.

Chemoreduction of Orbital Recurrence of Uveal Melanoma by Intra-Arterial Melphalan.

Francis JH, Barker CA, Yin VT, Carvajal RD, Chapman P, Abramson DH, Gobin YP.

Ocul Oncol Pathol. 2019 Apr;5(3):186-189. doi: 10.1159/000490061. Epub 2018 Oct 9.

8.

Organ preservation for patients with anterior mucosal squamous cell carcinoma of the nasal cavity: Rhinectomy-free survival in those refusing surgery.

Mimica X, Yu Y, McGill M, Barker CA, McBride S, Ganly I, Cracchiolo JR, Dunn LA, Katabi N, Sine K, Mah D, Lee A, Lee N, Cohen MA.

Head Neck. 2019 Aug;41(8):2741-2747. doi: 10.1002/hed.25751. Epub 2019 Apr 1.

PMID:
30933393
9.

Agricultural land-use history does not reduce woodland understory herb establishment.

Barker CA, Turley NE, Orrock JL, Ledvina JA, Brudvig LA.

Oecologia. 2019 Apr;189(4):1049-1060. doi: 10.1007/s00442-019-04348-6. Epub 2019 Mar 16.

PMID:
30879140
10.

Tumor mutational load predicts survival after immunotherapy across multiple cancer types.

Samstein RM, Lee CH, Shoushtari AN, Hellmann MD, Shen R, Janjigian YY, Barron DA, Zehir A, Jordan EJ, Omuro A, Kaley TJ, Kendall SM, Motzer RJ, Hakimi AA, Voss MH, Russo P, Rosenberg J, Iyer G, Bochner BH, Bajorin DF, Al-Ahmadie HA, Chaft JE, Rudin CM, Riely GJ, Baxi S, Ho AL, Wong RJ, Pfister DG, Wolchok JD, Barker CA, Gutin PH, Brennan CW, Tabar V, Mellinghoff IK, DeAngelis LM, Ariyan CE, Lee N, Tap WD, Gounder MM, D'Angelo SP, Saltz L, Stadler ZK, Scher HI, Baselga J, Razavi P, Klebanoff CA, Yaeger R, Segal NH, Ku GY, DeMatteo RP, Ladanyi M, Rizvi NA, Berger MF, Riaz N, Solit DB, Chan TA, Morris LGT.

Nat Genet. 2019 Feb;51(2):202-206. doi: 10.1038/s41588-018-0312-8. Epub 2019 Jan 14.

PMID:
30643254
11.

Imatinib Treatment for Locally Advanced or Metastatic Dermatofibrosarcoma Protuberans: A Systematic Review.

Navarrete-Dechent C, Mori S, Barker CA, Dickson MA, Nehal KS.

JAMA Dermatol. 2019 Mar 1;155(3):361-369. doi: 10.1001/jamadermatol.2018.4940.

PMID:
30601909
12.

Hepatic abnormalities identified by staging MRI and accuracy of MRI of patients with uveal melanoma.

Francis JH, Catalanotti F, Landa J, Barker CA, Shoushtari AN, Abramson DH.

Br J Ophthalmol. 2019 Sep;103(9):1266-1271. doi: 10.1136/bjophthalmol-2018-312612. Epub 2018 Oct 31.

PMID:
30381389
13.

Tumor Board Conferences for Multidisciplinary Skin Cancer Management: A Survey of US Cancer Centers.

Mori S, Navarrete-Dechent C, Petukhova TA, Lee EH, Rossi AM, Postow MA, Dunn LA, Roman BR, Yin VT, Coit DG, Hollmann TJ, Busam KJ, Nehal KS, Barker CA.

J Natl Compr Canc Netw. 2018 Oct;16(10):1209-1215. doi: 10.6004/jnccn.2018.7044.

14.

Local recurrence and quality of life after adjuvant radiation therapy in high-risk squamous cell carcinoma.

Yan BY, Kim SK, Ma J, Barker CA.

Br J Dermatol. 2019 Feb;180(2):417-418. doi: 10.1111/bjd.17244. Epub 2018 Nov 25. No abstract available.

PMID:
30244481
15.

Safety of combining thoracic radiation therapy with concurrent versus sequential immune checkpoint inhibition.

von Reibnitz D, Chaft JE, Wu AJ, Samstein R, Hellmann MD, Plodkowski AJ, Zhang Z, Shi W, Dick-Godfrey R, Panchoo KH, Barker CA, Rimner A.

Adv Radiat Oncol. 2018 May 9;3(3):391-398. doi: 10.1016/j.adro.2018.05.001. eCollection 2018 Jul-Sep.

16.

Adjuvant Pembrolizumab in Resected Stage III Melanoma.

Barker CA.

N Engl J Med. 2018 Aug 9;379(6):593. doi: 10.1056/NEJMc1807505. No abstract available.

PMID:
30091350
17.

New NCCN Guidelines for Uveal Melanoma and Treatment of Recurrent or Progressive Distant Metastatic Melanoma.

Barker CA, Salama AK.

J Natl Compr Canc Netw. 2018 May;16(5S):646-650. doi: 10.6004/jnccn.2018.0042.

PMID:
29784747
18.

Basal cell carcinoma: Contemporary approaches to diagnosis, treatment, and prevention.

Cameron MC, Lee E, Hibler BP, Giordano CN, Barker CA, Mori S, Cordova M, Nehal KS, Rossi AM.

J Am Acad Dermatol. 2019 Feb;80(2):321-339. doi: 10.1016/j.jaad.2018.02.083. Epub 2018 May 19. Review. Erratum in: J Am Acad Dermatol. 2019 Jul;81(1):310.

PMID:
29782901
19.

Basal cell carcinoma: Epidemiology; pathophysiology; clinical and histological subtypes; and disease associations.

Cameron MC, Lee E, Hibler BP, Barker CA, Mori S, Cordova M, Nehal KS, Rossi AM.

J Am Acad Dermatol. 2019 Feb;80(2):303-317. doi: 10.1016/j.jaad.2018.03.060. Epub 2018 May 18. Review.

PMID:
29782900
20.

Cytokine release syndrome after radiation therapy: case report and review of the literature.

Barker CA, Kim SK, Budhu S, Matsoukas K, Daniyan AF, D'Angelo SP.

J Immunother Cancer. 2018 Jan 3;6(1):1. doi: 10.1186/s40425-017-0311-9.

21.

Association of Surgical Approach and Margin Status With Oncologic Outcomes Following Gross Total Resection for Sinonasal Melanoma.

Sayed Z, Migliacci JC, Cracchiolo JR, Barker CA, Lee NY, McBride SM, Tabar VS, Ganly I, Patel SG, Morris LT, Roman BR, Shoushtari AN, Cohen MA.

JAMA Otolaryngol Head Neck Surg. 2017 Dec 1;143(12):1220-1227. doi: 10.1001/jamaoto.2017.2011. No abstract available.

22.

Medical marijuana for the treatment of vismodegib-related muscle spasm.

Yuan JT, Tello TL, Hultman C, Barker CA, Arron ST, Yom SS.

JAAD Case Rep. 2017 Sep 1;3(5):438-440. doi: 10.1016/j.jdcr.2017.06.012. eCollection 2017 Sep. No abstract available.

23.

A Serum Small Molecule Biosignature of Radiation Exposure from Total Body Irradiated Patients.

Laiakis EC, Pannkuk EL, Chauthe SK, Wang YW, Lian M, Mak TD, Barker CA, Astarita G, Fornace AJ Jr.

J Proteome Res. 2017 Oct 6;16(10):3805-3815. doi: 10.1021/acs.jproteome.7b00468. Epub 2017 Aug 31.

24.

Outcomes of radiation therapy for advanced T3/T4 nonmelanoma cutaneous squamous cell and basal cell carcinoma.

Kim SK, Barker CA.

Br J Dermatol. 2018 Jan;178(1):e30-e32. doi: 10.1111/bjd.15728. Epub 2017 Dec 6. No abstract available.

25.

Adjuvant Therapy in High-Risk Stage III Cutaneous Melanoma.

Barker CA.

Int J Radiat Oncol Biol Phys. 2017 May 1;98(1):11-12. doi: 10.1016/j.ijrobp.2017.02.213. No abstract available.

PMID:
28586947
26.

Metastatic cutaneous apocrine carcinoma: Multidisciplinary approach achieving complete response with adjuvant chemoradiation.

Hibler BP, Barker CA, Hollmann TJ, Rossi AM.

JAAD Case Rep. 2017 May 27;3(3):259-262. doi: 10.1016/j.jdcr.2017.03.006. eCollection 2017 May. No abstract available.

27.

Radiotherapy and Immune Checkpoint Blockade for Melanoma: A Promising Combinatorial Strategy in Need of Further Investigation.

Escorcia FE, Postow MA, Barker CA.

Cancer J. 2017 Jan/Feb;23(1):32-39. doi: 10.1097/PPO.0000000000000236. Review.

28.

A systematic review of comorbidity indices used in the nonmelanoma skin cancer population.

Connolly KL, Jeong JM, Barker CA, Hernandez M, Lee EH.

J Am Acad Dermatol. 2017 Feb;76(2):344-346.e2. doi: 10.1016/j.jaad.2016.10.007. Review. No abstract available.

29.

Skin surface brachytherapy: A survey of contemporary practice patterns.

Likhacheva AO, Devlin PM, Shirvani SM, Barker CA, Beron P, Bhatnagar A, Doggett SW, Hochman L, Hsu C, Kasper M, Keisch M, Mutyala S, Prestidge B, Rodriguez Villalba S, Shukla V, Sundararaman S, Kamrava M.

Brachytherapy. 2017 Jan - Feb;16(1):223-229. doi: 10.1016/j.brachy.2016.10.006. Epub 2016 Nov 28.

30.

The Molecular Landscape of Recurrent and Metastatic Head and Neck Cancers: Insights From a Precision Oncology Sequencing Platform.

Morris LGT, Chandramohan R, West L, Zehir A, Chakravarty D, Pfister DG, Wong RJ, Lee NY, Sherman EJ, Baxi SS, Ganly I, Singh B, Shah JP, Shaha AR, Boyle JO, Patel SG, Roman BR, Barker CA, McBride SM, Chan TA, Dogan S, Hyman DM, Berger MF, Solit DB, Riaz N, Ho AL.

JAMA Oncol. 2017 Feb 1;3(2):244-255. doi: 10.1001/jamaoncol.2016.1790.

31.

Dosimetric comparison of axilla and groin radiotherapy techniques for high-risk and locally advanced skin cancer.

Mattes MD, Zhou Y, Berry SL, Barker CA.

Radiat Oncol J. 2016 Jun;34(2):145-55. doi: 10.3857/roj.2015.01592. Epub 2016 Jun 17.

32.

Prognosis of Mucosal, Uveal, Acral, Nonacral Cutaneous, and Unknown Primary Melanoma From the Time of First Metastasis.

Kuk D, Shoushtari AN, Barker CA, Panageas KS, Munhoz RR, Momtaz P, Ariyan CE, Brady MS, Coit DG, Bogatch K, Callahan MK, Wolchok JD, Carvajal RD, Postow MA.

Oncologist. 2016 Jul;21(7):848-54. doi: 10.1634/theoncologist.2015-0522. Epub 2016 Jun 10.

33.

Impact of source position on high-dose-rate skin surface applicator dosimetry.

Jeong J, Barker CA, Zaider M, Cohen GN.

Brachytherapy. 2016 Sep-Oct;15(5):650-60. doi: 10.1016/j.brachy.2016.04.389. Epub 2016 Jun 1.

34.

Localized sinonasal mucosal melanoma: Outcomes and associations with stage, radiotherapy, and positron emission tomography response.

Samstein RM, Carvajal RD, Postow MA, Callahan MK, Shoushtari AN, Patel SG, Lee NY, Barker CA.

Head Neck. 2016 Sep;38(9):1310-7. doi: 10.1002/hed.24435. Epub 2016 Apr 4.

35.

Corticosteroids compromise survival in glioblastoma.

Pitter KL, Tamagno I, Alikhanyan K, Hosni-Ahmed A, Pattwell SS, Donnola S, Dai C, Ozawa T, Chang M, Chan TA, Beal K, Bishop AJ, Barker CA, Jones TS, Hentschel B, Gorlia T, Schlegel U, Stupp R, Weller M, Holland EC, Hambardzumyan D.

Brain. 2016 May;139(Pt 5):1458-71. doi: 10.1093/brain/aww046. Epub 2016 Mar 28.

36.

Electronic brachytherapy for superficial and nodular basal cell carcinoma: a report of two prospective pilot trials using different doses.

Ballester-Sánchez R, Pons-Llanas O, Candela-Juan C, Celada-Álvarez FJ, Barker CA, Tormo-Micó A, Pérez-Calatayud J, Botella-Estrada R.

J Contemp Brachytherapy. 2016 Feb;8(1):48-55. doi: 10.5114/jcb.2016.57531. Epub 2016 Jan 28.

37.

CRISPR/Cas9 Mutagenesis Reveals Versatile Roles of Hox Genes in Crustacean Limb Specification and Evolution.

Martin A, Serano JM, Jarvis E, Bruce HS, Wang J, Ray S, Barker CA, O'Connell LC, Patel NH.

Curr Biol. 2016 Jan 11;26(1):14-26. doi: 10.1016/j.cub.2015.11.021. Epub 2015 Dec 10.

38.

In reply to the Letter to the Editor titled: "Comments on: Clinical implementation of a new electronic brachytherapy system for skin brachytherapy".

Pons-Llanas O, Ballester-Sánchez R, Celada-Álvarez FJ, Candela-Juan C, García-Martínez T, Llavador-Ros M, Botella-Estrada R, Barker CA, Ballesta A, Tormo-Micó A, Rodríguez S, Perez-Calatayud J.

J Contemp Brachytherapy. 2015 Aug;7(4):319-20. doi: 10.5114/jcb.2015.53991. Epub 2015 Sep 14. No abstract available.

39.

Radiation Therapy for Cutaneous Melanoma: Clonogenic Assays to Clinical Trials.

Barker CA.

Oncology (Williston Park). 2015 Oct;29(10):752, 754. No abstract available.

40.

Efficacy and safety of electronic brachytherapy for superficial and nodular basal cell carcinoma.

Ballester-Sánchez R, Pons-Llanas O, Candela-Juan C, Celada-Alvarez FJ, de Unamuno-Bustos B, Llavador-Ros M, Ballesta-Cuñat A, Barker CA, Tormo-Mico A, Botella-Estrada R, Perez-Calatayud J.

J Contemp Brachytherapy. 2015 Jun;7(3):231-8. doi: 10.5114/jcb.2015.52140. Epub 2015 Jun 9.

41.

Comorbidity Assessment in Skin Cancer Patients: A Pilot Study Comparing Medical Interview with a Patient-Reported Questionnaire.

Lee EH, Nijhawan RI, Nehal KS, Dusza SW, Levine A, Hill A, Barker CA.

J Skin Cancer. 2015;2015:953479. doi: 10.1155/2015/953479. Epub 2015 Jun 9.

42.

Radiation therapy for synchronous basal cell carcinoma and lentigo maligna of the nose: Response assessment by clinical examination and reflectance confocal microscopy.

Hibler BP, Connolly KL, Cordova M, Nehal KS, Rossi AM, Barker CA.

Pract Radiat Oncol. 2015 Sep-Oct;5(5):e543-e547. doi: 10.1016/j.prro.2015.03.006. Epub 2015 Jul 2. No abstract available.

43.

Relationship Between Juncturae Tendinum and Sagittal Bands.

Chinchalkar SJ, Barker CA, Owsley B.

J Hand Microsurg. 2015 Jun;7(1):96-101. doi: 10.1007/s12593-015-0172-8. Epub 2015 Jan 17. Review.

44.

Clinical implementation of a new electronic brachytherapy system for skin brachytherapy.

Pons-Llanas O, Ballester-Sánchez R, Celada-Álvarez FJ, Candela-Juan C, García-Martínez T, Llavador-Ros M, Botella-Estrada R, Barker CA, Ballesta A, Tormo-Micó A, Rodríguez S, Perez-Calatayud J.

J Contemp Brachytherapy. 2015 Jan;6(4):417-23. doi: 10.5114/jcb.2014.47996. Epub 2014 Dec 31. Review.

45.

Stereotactic radiosurgery for melanoma brain metastases in patients receiving ipilimumab: safety profile and efficacy of combined treatment.

Kiess AP, Wolchok JD, Barker CA, Postow MA, Tabar V, Huse JT, Chan TA, Yamada Y, Beal K.

Int J Radiat Oncol Biol Phys. 2015 Jun 1;92(2):368-75. doi: 10.1016/j.ijrobp.2015.01.004. Epub 2015 Mar 5.

46.

Intraoperative high-dose rate of radioactive phosphorus 32 brachytherapy for diffuse recalcitrant conjunctival neoplasms: a retrospective case series and report of toxicity.

Marr BP, Abramson DH, Cohen GN, Williamson MJ, McCormick B, Barker CA.

JAMA Ophthalmol. 2015 Mar;133(3):283-9. doi: 10.1001/jamaophthalmol.2014.5079.

47.

Blue lighting decreases the amount of food consumed in men, but not in women.

Cho S, Han A, Taylor MH, Huck AC, Mishler AM, Mattal KL, Barker CA, Seo HS.

Appetite. 2015 Feb;85:111-7. doi: 10.1016/j.appet.2014.11.020. Epub 2014 Nov 20.

PMID:
25447013
48.

Survival of patients treated with radiation therapy for anaplastic astrocytoma.

Barker CA, Chang M, Beal K, Chan TA.

Radiol Oncol. 2014 Nov 5;48(4):381-6. doi: 10.2478/raon-2014-0019. eCollection 2014 Dec.

49.

Ipilimumab and whole brain radiation therapy for melanoma brain metastases.

Gerber NK, Young RJ, Barker CA, Wolchok JD, Chan TA, Yamada Y, Friguglietti L, Beal K.

J Neurooncol. 2015 Jan;121(1):159-65. doi: 10.1007/s11060-014-1617-9. Epub 2014 Oct 2.

50.

Efficacy of skin-directed therapy for cutaneous metastases from advanced cancer: a meta-analysis.

Spratt DE, Gordon Spratt EA, Wu S, DeRosa A, Lee NY, Lacouture ME, Barker CA.

J Clin Oncol. 2014 Oct 1;32(28):3144-55. doi: 10.1200/JCO.2014.55.4634. Epub 2014 Aug 25.

Supplemental Content

Loading ...
Support Center